Список проголосовавших за комментарий " Gapping up/down: AAOI +19%, LTRX +17%, LEDS +16% after earnings, MRK +1% after upgreade; DRWI -14% after earnings, X -2%, VFC -1% and DIS -1% after downgrades<p><strong>Gapping up <br/> In reaction to strong earnings/guidance</strong>:</p><ul><li><strong>AAOI</strong> +18.8%, <strong>LTRX</strong> +16.9%, <strong>LEDS</strong> +15.7%, <strong>BLFS</strong> +11.2%, <strong>FCEL</strong> +7.7%, <strong>QTM</strong> +6.9%, <strong>VISI</strong> +5.2%, <strong>KBH</strong> +0.8%, <strong>REG</strong> +0.5%</li></ul><p><strong>Select metals/mining stocks trading higher</strong>: <strong>GFI</strong> +4.3%, <strong>SBGL</strong> +3.3%, <strong>MUX</strong> +2.9%, <strong>RIO</strong> +2.9%, <strong>CDE</strong> +2.6%, <strong>HMY</strong> +2.5%, <strong>KGC</strong> +2.4%, <strong>AG</strong> +2.3%, <strong>SLW</strong> +2.3%, <strong>ABX</strong> +2.2%, <strong>AUY</strong> +2.2%, <strong>PAAS</strong> +2.2%, <strong>GDX</strong> +2.1%, <strong>BBL</strong> +2.1%, <strong>BHP</strong> +2.1%, <strong>AGI</strong> +2%, <strong>NEM</strong>+1.9%, <strong>VALE</strong> +1.6%, <strong>AA</strong> +1.3%</p><p><strong>Select AAOI peers showing strength</strong>: <strong>OCLR</strong> +3.3%, <strong>ACIA</strong> +1.5%, <strong>LITE</strong> +1.2%, <strong>NPTN</strong> +0.5%</p><p><strong>Other news</strong>:</p><ul><li>N<strong>TBIO</strong> +127.6% (Lifelabs selected its ICE COLD-PCR technology as its mutation enrichment platform for cancer testing), <strong>HSGX</strong> +28.3% (announces an online publication in the American Journal of Sports Medicine; results from the two studies indicate that NeoCart is a safe & effective treatment for articular cartilage lesions through 5-year follow-up), <strong>MICT</strong> +15% (receives 3 purchase orders from 2 aerospace & defense contractors), <strong>ALIOY</strong> +4.9% (Bloomberg sources indicated Johnson & Johnson / Actelion agreed to price), <strong>GPAC</strong> +3.4% (enters into definitive merger with Sequel Youth and Family Services), <strong>ASIX</strong> +3.2% (among stocks with favorable commentary on Wednesday's Mad Money), <strong>BW</strong> +2.7% (Babcock & Wilcox Enterprises acquired Universal Acoustic & Emission Technologies effective today; expected to be accretive in 2017), <strong>ELY</strong> +1.4% (acquires OGIO International for $75.5 mln in an all-cash transaction; Callaway's management expects the acquisition to be immediately accretive to earnings)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>MRK</strong> +1.4% (upgraded to Overweight from Equal-Weight at Morgan Stanley)</li></ul><p><strong>Gapping down<br/> In reaction to disappointing earnings/guidance</strong>:</p><ul><li><strong>DRWI</strong> -13.8%, <strong>SAR</strong> -0.9%, <strong>SJR</strong> -0.9%, <strong>WMS</strong> -0.7%, <strong>TSM</strong> -0.6%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>MYOS</strong> -24.8% (after closing near highs — up 25% on the day; MYOS RENS Tech. says a Court has granted it the preliminary restraints that it requested against RENS Agriculture)</li><li><strong>ETRM</strong> -11% (continued volatility in the pre-mkt)</li><li><strong>KOS</strong> -7.4% (announces secondary public offering of common shares)</li><li><strong>NAK</strong> -7.1% (announces $25 mln bought deal; syndicate agreed to purchase 13.52 mln common shares at $1.85/offered share)</li><li><strong>ABIO</strong> -3.6% (thinly traded; enters into a Capital on Demand Sales Agreement with JonesTrading Institutional Services under which it may offer and sell shares of common stock having an aggregate offering price of up to $7.3 mln)</li><li><strong>TSRO</strong> -3.4% (receives Complete Response Letter for Rolapitant IV)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>GATX</strong> -4.9% (downgraded to Sell at Stifel)</li><li><strong>X</strong> -2.6% (downgraded to Neutral from Outperform at Credit Suisse)</li><li><strong>NSIT</strong> -2.1% (downgraded to Underperform from Mkt Perform at Raymond James)</li><li><strong>VFC</strong> -1.2% (downgraded to Hold from Buy at Canaccord Genuity)</li><li><strong>AKS</strong> -1.1% (downgraded to Neutral from Outperform at Credit Suisse)</li><li><strong>DIS</strong> -1.1% (downgraded to Sell form Hold at Pivotal Research)</li><li><strong>TWTR</strong> -0.7% (downgraded to Hold from Buy at Pivotal Research)</li><li><strong>AAPL</strong> -0.6% (RBC lowers estimates)</li></ul>"